<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Translocations involving c-myc and an Ig locus have been reported rarely in human <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> (MM) </plain></SENT>
<SENT sid="1" pm="."><plain>Using specific fluorescence in situ hybridization probes, we show complex karyotypic abnormalities of the c-myc or L-myc locus in 19 of 20 MM cell lines and approximately 50% of advanced primary MM <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>These abnormalities include unusual and complex translocations and insertions that often juxtapose myc with an IgH or IgL locus </plain></SENT>
<SENT sid="3" pm="."><plain>For two advanced primary MM <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, some <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells contain a karyotypic abnormality of the c-myc locus, whereas other <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells do not, indicating that this karyotypic abnormality of c-myc occurs as a late event </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> informative MM cell lines show monoallelic expression of c-myc </plain></SENT>
<SENT sid="5" pm="."><plain>For Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and mouse <z:hpo ids='HP_0011857'>plasmacytoma</z:hpo> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, balanced translocation that juxtaposes c-myc with one of the Ig loci is an early, invariant event that is mediated by B cell-specific DNA modification mechanisms </plain></SENT>
<SENT sid="6" pm="."><plain>By contrast, for MM, dysregulation of c-myc apparently is caused principally by complex genomic rearrangements that occur during late stages of MM progression and do not involve B cell-specific DNA modification mechanisms </plain></SENT>
</text></document>